Clarivate (NYSE:CLVT – Get Free Report) updated its FY 2026 earnings guidance on Monday. The company provided earnings per share guidance of 0.700-0.800 for the period, compared to the consensus estimate of 0.720. The company issued revenue guidance of $2.3 billion-$2.4 billion, compared to the consensus revenue estimate of $2.4 billion.
Wall Street Analysts Forecast Growth
Several analysts have issued reports on the company. Weiss Ratings restated a “sell (e+)” rating on shares of Clarivate in a report on Wednesday, June 24th. Barclays upped their price target on Clarivate from $2.40 to $2.50 and gave the company an “underweight” rating in a research note on Tuesday. Finally, Wall Street Zen upgraded Clarivate from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Five investment analysts have rated the stock with a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Reduce” and a consensus target price of $3.23.
View Our Latest Stock Analysis on CLVT
Clarivate Price Performance
Clarivate (NYSE:CLVT – Get Free Report) last issued its earnings results on Wednesday, April 29th. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.14 by $0.04. Clarivate had a negative net margin of 5.61% and a positive return on equity of 8.82%. The business had revenue of $585.50 million for the quarter, compared to the consensus estimate of $569.50 million. During the same quarter in the previous year, the firm earned $0.14 earnings per share. The business’s quarterly revenue was down 1.4% compared to the same quarter last year. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. On average, equities research analysts anticipate that Clarivate will post 0.65 earnings per share for the current year.
Institutional Inflows and Outflows
Several large investors have recently made changes to their positions in CLVT. Jump Financial LLC purchased a new stake in Clarivate during the 4th quarter worth $41,000. PharVision Advisers LLC acquired a new stake in shares of Clarivate in the third quarter valued at about $45,000. Pitcairn Co. acquired a new position in shares of Clarivate in the 2nd quarter valued at approximately $52,000. RPO LLC acquired a new position in shares of Clarivate in the 4th quarter valued at approximately $64,000. Finally, Corsair Capital Management L.P. purchased a new position in shares of Clarivate during the 4th quarter valued at approximately $67,000. 85.72% of the stock is owned by hedge funds and other institutional investors.
Clarivate Company Profile
Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.
Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.
Featured Articles
- Five stocks we like better than Clarivate
- Apple and Broadcom Forge a Decade-Long Silicon Fortress
- SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
- The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity
- Palantir’s CEO Just Called Out OpenAI and Anthropic
Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.
